MGNX logo

MacroGenics (MGNX) Shareholders Equity

Annual Shareholders Equity

$152.61 M
+$10.60 M+7.46%

31 December 2023

MGNX Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$120.07 M
+$62.25 M+107.66%

30 September 2024

MGNX Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MGNX Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.5%-38.1%
3 y3 years-48.4%-58.8%
5 y5 years-37.2%-53.0%

MGNX Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-48.4%+7.5%-58.8%+107.7%
5 y5 years-48.4%+7.5%-65.8%+107.7%
alltimeall time-51.3%+972.9%-65.8%+1198.5%

MacroGenics Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$120.07 M(+107.7%)
June 2024
-
$57.82 M(-45.5%)
Mar 2024
-
$106.15 M(-30.4%)
Dec 2023
$152.61 M(+7.5%)
$152.61 M(-21.3%)
Sept 2023
-
$193.98 M(+13.1%)
June 2023
-
$171.54 M(+57.0%)
Mar 2023
-
$109.27 M(-23.1%)
Dec 2022
$142.01 M(-40.7%)
$142.01 M(+15.5%)
Sept 2022
-
$122.96 M(-13.7%)
June 2022
-
$142.48 M(-20.1%)
Mar 2022
-
$178.21 M(-25.6%)
Dec 2021
$239.62 M(-19.0%)
$239.62 M(-17.8%)
Sept 2021
-
$291.44 M(-8.7%)
June 2021
-
$319.05 M(-9.0%)
Mar 2021
-
$350.53 M(+18.5%)
Dec 2020
$295.88 M(+28.3%)
$295.88 M(+1.5%)
Sept 2020
-
$291.58 M(+17.7%)
June 2020
-
$247.78 M(+30.0%)
Mar 2020
-
$190.57 M(-17.4%)
Dec 2019
$230.63 M(-5.0%)
$230.63 M(-9.6%)
Sept 2019
-
$255.20 M(-13.3%)
June 2019
-
$294.45 M(-8.2%)
Mar 2019
-
$320.62 M(+32.0%)
Dec 2018
$242.88 M
$242.88 M(-14.1%)
DateAnnualQuarterly
Sept 2018
-
$282.64 M(-9.4%)
June 2018
-
$312.04 M(+26.2%)
Mar 2018
-
$247.28 M(-17.4%)
Dec 2017
$299.24 M(+11.3%)
$299.24 M(+57.9%)
Sept 2017
-
$189.47 M(-18.1%)
June 2017
-
$231.35 M(-1.4%)
Mar 2017
-
$234.64 M(-12.7%)
Dec 2016
$268.75 M(-14.2%)
$268.75 M(-10.4%)
Sept 2016
-
$300.10 M(-9.1%)
June 2016
-
$329.98 M(+15.3%)
Mar 2016
-
$286.25 M(-8.6%)
Dec 2015
$313.34 M(+158.3%)
$313.34 M(-7.7%)
Sept 2015
-
$339.33 M(+60.3%)
June 2015
-
$211.69 M(-8.4%)
Mar 2015
-
$230.99 M(+90.5%)
Dec 2014
$121.29 M(+53.7%)
$121.29 M(-12.8%)
Sept 2014
-
$139.09 M(-2.0%)
June 2014
-
$141.98 M(-7.3%)
Mar 2014
-
$153.22 M(+94.2%)
Dec 2013
$78.91 M(-1058.0%)
$78.91 M(-2049.3%)
Sept 2013
-
-$4.05 M(-63.0%)
June 2013
-
-$10.93 M(+32.7%)
Dec 2012
-$8.24 M(-52.9%)
-$8.24 M
Dec 2011
-$17.48 M
-

FAQ

  • What is MacroGenics annual stockholders equity?
  • What is the all time high annual shareholders equity for MacroGenics?
  • What is MacroGenics annual shareholders equity year-on-year change?
  • What is MacroGenics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for MacroGenics?
  • What is MacroGenics quarterly shareholders equity year-on-year change?

What is MacroGenics annual stockholders equity?

The current annual shareholders equity of MGNX is $152.61 M

What is the all time high annual shareholders equity for MacroGenics?

MacroGenics all-time high annual stockholders equity is $313.34 M

What is MacroGenics annual shareholders equity year-on-year change?

Over the past year, MGNX annual stockholders equity has changed by +$10.60 M (+7.46%)

What is MacroGenics quarterly stockholders equity?

The current quarterly shareholders equity of MGNX is $120.07 M

What is the all time high quarterly shareholders equity for MacroGenics?

MacroGenics all-time high quarterly stockholders equity is $350.53 M

What is MacroGenics quarterly shareholders equity year-on-year change?

Over the past year, MGNX quarterly stockholders equity has changed by -$73.91 M (-38.10%)